Valid for Submission
D57.213 is a billable diagnosis code used to specify a medical diagnosis of sickle-cell/hb-c disease with cerebral vascular involvement. The code D57.213 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
New 2021 ICD-10 Code
D57.213 is new to ICD-10 code set for the FY 2021, effective October 1, 2020. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2020. This is a new and revised code for the FY 2021 (October 1, 2020 - September 30, 2021).
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D57.213:
Code AlsoCode Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- , if applicable, cerebral infarction I63
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D57.213 are found in the index:
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|811||RED BLOOD CELL DISORDERS WITH MCC||16||1.3776|
|812||RED BLOOD CELL DISORDERS WITHOUT MCC||16||0.8797|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
D57213 replaces the following previously assigned ICD-10 code(s):